1. Home
  2. CDNA vs VCEL Comparison

CDNA vs VCEL Comparison

Compare CDNA & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$53.96

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$39.98

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
VCEL
Founded
1998
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.4B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
CDNA
VCEL
Price
$53.96
$39.98
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$28.00
$57.75
AVG Volume (30 Days)
1.0M
455.8K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
2.13
N/A
Revenue
$48,324,000.00
$276,259,000.00
Revenue This Year
$16.01
$19.40
Revenue Next Year
$11.31
$18.24
P/E Ratio
$25.48
N/A
Revenue Growth
18.93
16.45
52 Week Low
$13.95
$28.95
52 Week High
$55.16
$49.32

Technical Indicators

Market Signals
Indicator
CDNA
VCEL
Relative Strength Index (RSI) 69.87 42.76
Support Level $45.74 $35.32
Resistance Level N/A $41.25
Average True Range (ATR) 2.17 1.23
MACD -0.00 0.15
Stochastic Oscillator 85.84 63.53

Price Performance

Historical Comparison
CDNA
VCEL

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: